{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:29:05Z","timestamp":1794533345433,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":230,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26K18581"],"award-info":[{"award-number":["26K18581"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101392","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:11:43Z","timestamp":1787670703000},"page":"101392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinicopathological features of LOXL1-expressing non-small cell lung cancer: relation to the extent of CD8+ T-cell infiltration"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0181-1334","authenticated-orcid":false,"given":"Yuki","family":"Hanamatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101392_bib0001","doi-asserted-by":"crossref","unstructured":"H. Borghaei, L. Paz-Ares, L. Horn, D.R. Spigel, M. Steins, N.E. Ready, L.Q. Chow, E.E. Vokes, E. Felip, E. Holgado, F. Barlesi, M. Kohlh\u00e4ufl, O. Arrieta, M.A. Burgio, J. Fayette, H. Lena, E. Poddubskaya, D.E. Gerber, S.N. Gettinger, C.M. Rudin, N. Rizvi, L. Crin\u00f2, G.R. Blumenschein Jr, S.J. Antonia, C. Dorange, C.T. Harbison, F. Graf Finckenstein, J.R. Brahmer, Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer, N. Engl. J. Med. 373 (2015) 1627\u20131639. https:\/\/doi.org\/10.1056\/NEJMoa1507643. EPub. https:\/\/pubmed.ncbi.nlm.nih.gov\/26412456\/,https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5705936\/.","DOI":"10.1056\/NEJMoa1507643"},{"key":"10.1016\/j.ctarc.2026.101392_bib0002","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"KEYNOTE-189 Investigators, Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101392_bib0003","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.ccell.2025.06.012","article-title":"Subclonal immune evasion in non-small cell lung cancer","volume":"43","author":"Dijkstra","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2026.101392_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(01)70012-8","article-title":"Lysyl oxidases: a novel multifunctional amine oxidase family","volume":"70","author":"Csiszar","year":"2001","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.ctarc.2026.101392_bib0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1570-9639(03)00053-0","article-title":"Structural and functional diversity of lysyl oxidase and the LOX-like proteins","volume":"1647","author":"Molnar","year":"2003","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.ctarc.2026.101392_bib0006","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/EBC20180050","article-title":"Lysyl oxidases: from enzyme activity to extracellular matrix cross-links","volume":"63","author":"Vallet","year":"2019","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ctarc.2026.101392_bib0007","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3319","article-title":"The rationale for targeting the LOX family in cancer","volume":"12","author":"Barker","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101392_bib0008a","doi-asserted-by":"crossref","first-page":"60015","DOI":"10.18632\/oncotarget.9623","article-title":"Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients","volume":"8","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctarc.2026.101392_bib0008b","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5601118\/."},{"key":"10.1016\/j.ctarc.2026.101392_bib0009","article-title":"LOX expression and functional analysis in astrocytomas and impact of IDH1 mutation","volume":"10","author":"da Silva","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ctarc.2026.101392_bib0010","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.dld.2022.09.003","article-title":"LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry","volume":"55","author":"Zhao","year":"2023","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ctarc.2026.101392_bib0011","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/03936155251396145","article-title":"Human lysine oxidase-like 3 high expression as a potential biomarker and association with poor prognosis in pleural mesothelioma","volume":"40","author":"Mei","year":"2025","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.ctarc.2026.101392_bib0012","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1046\/j.1471-4159.2000.0741489.x","article-title":"Expression of T-cadherin (CDH13, H-Cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells","volume":"74","author":"Takeuchi","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ctarc.2026.101392_bib0013a","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ctarc.2026.101392_bib0013b","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8809887\/."},{"key":"10.1016\/j.ctarc.2026.101392_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149312","article-title":"The Oncogenic role of Lysyl Oxidase-Like 1 (LOXL1): insights into cancer progression and therapeutic potential","volume":"947","author":"Zhao","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.ctarc.2026.101392_bib0015","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1159\/000438523","article-title":"Prognostic role of tumor-infiltrating lymphocytes in lung cancer: a meta-analysis","volume":"37","author":"Geng","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ctarc.2026.101392_bib0016","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1158\/1078-0432.CCR-08-0133","article-title":"Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer","volume":"14","author":"Al-Shibli","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101392_bib0017a","first-page":"831","article-title":"Lysyl oxidase-like-1 enhances lung metastasis when lactate accumulation and monocarboxylate transporter expression are involved","volume":"2","author":"Lee","year":"2011","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ctarc.2026.101392_bib0017b","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3408044\/."},{"key":"10.1016\/j.ctarc.2026.101392_bib0018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.semtcvs.2011.07.001","article-title":"Sex and gender differences in non-small cell lung cancer","volume":"23","author":"Donington","year":"2011","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ctarc.2026.101392_bib0019","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/jnci\/92.21.1764","article-title":"Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study","volume":"92","author":"Wei","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ctarc.2026.101392_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/humu.10177","article-title":"The TP53 gene, tobacco exposure, and lung cancer","volume":"21","author":"Toyooka","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ctarc.2026.101392_bib0021","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/jnci\/92.1.24","article-title":"Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer","volume":"92","author":"Shriver","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ctarc.2026.101392_bib0022","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0169-5002(00)00163-X","article-title":"Gender differences in genetic susceptibility for lung cancer","volume":"30","author":"Dresler","year":"2000","journal-title":"Lung Cancer"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:11:18Z","timestamp":1794532278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"alternative-id":["S2468294226003035"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101392","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological features of LOXL1-expressing non-small cell lung cancer: relation to the extent of CD8+ T-cell infiltration","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101392"}}